in Human Systemic Lupus Erythematosus Molecular Basis of 9G4 B Cell Autoreactivity

9G4 + IgG Abs expand in systemic lupus erythematosus (SLE) in a disease-specific fashion and react with different lupus Ags including B cell Ags and apoptotic cells. Their shared use of VH4-34 represents a unique system to understand the molecular basis of lupus autoreactivity. In this study, a large panel of recombinant 9G4 + mAbs from single naive and memory cells was generated and tested against B cells, apoptotic cells, and other Ags. Mutagenesis eliminated the framework-1 hydrophobic patch (HP) responsible for the 9G4 idiotype. The expression of the HP in unselected VH4-34 cells was assessed by deep sequencing. We found that 9G4 Abs recognize several Ags following two distinct structural patterns. B cell binding is dependent on the HP, whereas anti-nuclear Abs, apoptotic cells, and dsDNA binding are HP independent and correlate with positively charged H chain third CDR. The majority of mutated VH4-34 memory cells retain the HP, thereby suggesting selection by Ags that require this germline structure. Our findings show that the germline-encoded HP is compulsory for the anti–B cell reactivity largely associated with 9G4 Abs in SLE but is not required for reactivity against apoptotic cells, dsDNA, chromatin, anti-nuclear Abs, or cardiolipin. Given that the lupus memory compartment contains a majority of HP + VH4-34 cells but decreased B cell reactivity, additional HP-dependent Ags must participate in the selection of this compartment. This study represents the first analysis, to our knowl-edge,

[1]  T. Kepler,et al.  Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies , 2013, The Journal of experimental medicine.

[2]  M. Weigert,et al.  B cell receptor light chain repertoires show signs of selection with differences between groups of healthy individuals and SLE patients. , 2012, Molecular immunology.

[3]  James L. Zehnder,et al.  High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment , 2011, Proceedings of the National Academy of Sciences.

[4]  M. Nussenzweig,et al.  Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells , 2011, Proceedings of the National Academy of Sciences.

[5]  Hongmei Yang,et al.  Anergic Responses Characterize a Large Fraction of Human Autoreactive Naive B Cells Expressing Low Levels of Surface IgM , 2011, The Journal of Immunology.

[6]  Michal Barak,et al.  Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. , 2010, Journal of autoimmunity.

[7]  N. Chiorazzi,et al.  Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. , 2010, Blood.

[8]  K. Lauber,et al.  The role of defective clearance of apoptotic cells in systemic autoimmunity , 2010, Nature Reviews Rheumatology.

[9]  I. Sanz,et al.  B cells and immunological tolerance. , 2009, The Journal of investigative dermatology.

[10]  B. Nakken,et al.  Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors , 2009, The Journal of experimental medicine.

[11]  M. Bianchi,et al.  Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE , 2008, The Journal of experimental medicine.

[12]  J. Casanova,et al.  IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. , 2008, Immunity.

[13]  L. Davis,et al.  Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. , 2008, Immunity.

[14]  M. Shlomchik,et al.  Sites and stages of autoreactive B cell activation and regulation. , 2008, Immunity.

[15]  M. Nussenzweig,et al.  Autoreactivity in human IgG+ memory B cells. , 2007, Immunity.

[16]  O. Rekvig,et al.  Cardiovascular, Pulmonary and Renal Pathology Nephritogenic Lupus Antibodies Recognize Glomerular Basement Membrane-Associated Chromatin Fragments Released from Apoptotic Intraglomerular Cells , 2006 .

[17]  P. Chandaroy,et al.  Accelerated Macrophage Apoptosis Induces Autoantibody Formation and Organ Damage in Systemic Lupus Erythematosus1 , 2006, The Journal of Immunology.

[18]  B. Vilen,et al.  Early Preplasma Cells Define a Tolerance Checkpoint for Autoreactive B Cells1 , 2006, The Journal of Immunology.

[19]  Chandra Mohan,et al.  Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. , 2005, The Journal of clinical investigation.

[20]  A. Cappione,et al.  Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. , 2005, The Journal of clinical investigation.

[21]  E. Reefman,et al.  Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement , 2005, Annals of the rheumatic diseases.

[22]  V. Pascual,et al.  Defective B cell tolerance checkpoints in systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[23]  E. Meffre,et al.  Impaired early B cell tolerance in patients with rheumatoid arthritis , 2005, The Journal of experimental medicine.

[24]  E. Milner,et al.  Human innate B cells: a link between host defense and autoimmunity? , 2005, Springer Seminars in Immunopathology.

[25]  John C Hall,et al.  Altered structure of autoantigens during apoptosis. , 2004, Rheumatic diseases clinics of North America.

[26]  M. Nussenzweig,et al.  Human Autoantibody Silencing by Immunoglobulin Light Chains , 2004, The Journal of experimental medicine.

[27]  A. Cappione,et al.  Lupus IgG VH4.34 Antibodies Bind to a 220-kDa Glycoform of CD45/B220 on the Surface of Human B Lymphocytes1 , 2004, The Journal of Immunology.

[28]  S. Eda,et al.  Carbohydrate-mediated Phagocytic Recognition of Early Apoptotic Cells Undergoing Transient Capping of CD43 Glycoprotein* , 2004, Journal of Biological Chemistry.

[29]  M. Nussenzweig,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.

[30]  N. Teng,et al.  VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype. , 2002, The Journal of rheumatology.

[31]  B. Namjou,et al.  Genetic linkage of systemic lupus erythematosus with chromosome 11q14 (SLEH1) in African-American families stratified by a nucleolar antinuclear antibody pattern , 2002, Genes and Immunity.

[32]  M. Radic,et al.  Editors and editing of anti-DNA receptors. , 2001, Immunity.

[33]  M. Radic,et al.  Structural basis for autoantibody recognition of phosphatidylserine-β2 glycoprotein I and apoptotic cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Cappione,et al.  Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. , 2001, The Journal of clinical investigation.

[35]  N. Kiyokawa,et al.  CD24 Induces Apoptosis in Human B Cells Via the Glycolipid-Enriched Membrane Domains/Rafts-Mediated Signaling System1 , 2001, The Journal of Immunology.

[36]  J. Harley,et al.  Delineation of the Human Systemic Lupus Erythematosus Anti-Smith Antibody Response Using Phage-Display Combinatorial Libraries1 , 2000, The Journal of Immunology.

[37]  I. Sanz,et al.  Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries. , 2000, Clinical immunology.

[38]  Stevenson,et al.  Recognition of Auto‐ and Exoantigens by V4‐34 Gene Encoded Antibodies , 2000, Scandinavian journal of immunology.

[39]  K. Richards,et al.  VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics. , 1999, The Journal of rheumatology.

[40]  D. Isenberg,et al.  Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus , 1998, Annals of the rheumatic diseases.

[41]  C. Chapman,et al.  Rapid cytotoxicity of human B lymphocytes induced by VH4‐34 (VH4.21) gene‐encoded monoclonal antibodies, II , 1997, Clinical and experimental immunology.

[42]  D. Isenberg,et al.  Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope. , 1996, Journal of immunology.

[43]  N. Teng,et al.  Rapid cytotoxicity of human B lymphocytes induced by VH4‐34 (VH4.21) gene‐encoded monoclonal antibodies , 1996, Clinical and experimental immunology.

[44]  J. D. Capra,et al.  The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. , 1996, Journal of molecular biology.

[45]  K. Potter,et al.  The Cross‐Reactive Idiotopes Recognized by the Monoclonal Antibodies 9G4 and LCI are Located in Framework Region 1 of Two Non‐Overlapping Subsets of Human VH4 Family Encoded Antibodies , 1994, Scandinavian journal of immunology.

[46]  D. Isenberg,et al.  Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. , 1993, Journal of autoimmunity.

[47]  V. Pascual,et al.  Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment , 1993, The Journal of experimental medicine.

[48]  D. Isenberg,et al.  Identification of the 9G4 idiotope in systemic lupus erythematosus. , 1993, British journal of rheumatology.

[49]  C. Chapman,et al.  Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment. , 1993, Journal of immunology.

[50]  L. Rassenti,et al.  An anti‐B cell autoantibody from Wiskott‐Aldrich syndrome which recognizes i blood group specificity on normal human B cells , 1992, European journal of immunology.

[51]  W. Pruzanski,et al.  Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. , 1991, Blood.

[52]  I. Sanz,et al.  Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. , 1991, Journal of immunology.

[53]  J. D. Capra,et al.  Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. , 1989, Journal of immunology.

[54]  M. Takei,et al.  VH sequence of a human anti-Sm autoantibody. Evidence that autoantibodies can be unmutated copies of germline genes. , 1989, Journal of immunology.

[55]  D. Isenberg,et al.  Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients. , 1985, The Journal of clinical investigation.

[56]  J. Paulson,et al.  Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type , 1984, Nature.

[57]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[58]  T. Feizi Blood Group Antigens , 1975, Proceedings of the Royal Society of Medicine.

[59]  T. Feizi,et al.  A common idiotype on human macroglobulins with anti-I and anti-i specificity. , 1975, Clinical and experimental immunology.

[60]  J. D. Capra,et al.  Structure of antibodies with shared idiotypy: the complete sequence of the heavy chain variable regions of two immunoglobulin M anti-gamma globulins. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Cohn,et al.  Variability in the Lambda Light Chain Sequences of Mouse Antibody , 1970, Nature.

[62]  W. Epstein,et al.  Specificity and reactivity of cytoplasmic and nucleolar antibody in SLE sera. , 1969, Arthritis and rheumatism.

[63]  T. Feizi Monotypic Cold Agglutinins in Infection by Mycoplasma pneumoniae , 1967, Nature.

[64]  Michel C Nussenzweig,et al.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.

[65]  R. Voll,et al.  Clearance of apoptotic cells in human SLE. , 2006, Current directions in autoimmunity.

[66]  L. Rönnblom,et al.  Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. , 2003, Journal of immunology.

[67]  C. Chapman,et al.  A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1. , 1999, Human antibodies.

[68]  C. Chapman,et al.  Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene. A possible link between infection and lupus. , 1995, Annals of the New York Academy of Sciences.

[69]  M. Radic,et al.  Genetic and structural evidence for antigen selection of anti-DNA antibodies. , 1994, Annual review of immunology.

[70]  T. Feizi Cold agglutinin titres, cold agglutinin structure and serum immunoglobulin levels in a variety of syndromes including mycoplasma pneumoniae infection. , 1968, Bibliotheca haematologica.

[71]  M. M. Hargraves Production in vitro of the L.E. cell phenomenon; use of normal bone marrow elements and blood plasma from patients with acute disseminated lupus erythematosus. , 1949, Proceedings of the staff meetings. Mayo Clinic.